marijuana stock news

INSYS Therapeutics Slumps: INSY Falls 7% in Session – Tale of the Tape

INSYS Therapeutics, Inc. (INSY) saw a big move last session, as the company’s shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for INSY as the stock is now up by over 14% since Feb 4.

On Mar 2, The Shuman Law Firm announced that it is investigating potential claims against certain officers and directors of INSYS Therapeutics.

The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases), and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

INSY currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the same sector is Abaxis, Inc. (ABAX), holding a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

INSYS THERAP (INSY): Free Stock Analysis Report

ABAXIS INC (ABAX): Free Stock Analysis Report

To read this article on Zacks.com click here.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

High Tide Inc. (HITI) to Open Two New Canna Cabana Retail Cannabis Stores to Mark 4/20 Holiday

High Tide to Open Two New Canna Cabana Retail Cannabis Stores to…

$PMCB Cell-in-a-Box Technology Makes Good Cancer Drugs Better

PharmaCyte Biotech’s Cell-in-a-Box Technology Makes Good Cancer Drugs Better While many biotech…

Organigram Holdings Inc. (OGRMF) becomes one of the first licensed producers to sign MOU

Organigram becomes one of the first licensed producers to sign MOU with…

Aphria Inc. (APHQF) Completes Largest Export Shipment to Date to Medlab Australia

Aphria Completes Largest Export Shipment to Date to Medlab Australia Aphria Inc.…